Ctic stock earnings
WebApr 10, 2024 · CTIC Stock Overview. CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. ... Earnings-US$92.99m: Last Reported Earnings. Dec 31, 2024. Next Earnings Date. n/a. Earnings per share (EPS)-0.71: … WebStock CTIC . Posted: Apr 12 2024, 16:30. Author Name: PRNewsWire. Views: 041225. CTIC News . By PRNewsWire April 12, 2024. CTI BioPharma to Participate in Two Upcoming Investor Conferences in April 2024 ... CTI BioPharma (CTIC) delivered earnings and revenue surprises of -55.56% and 15.24%, respectively, for the quarter ended …
Ctic stock earnings
Did you know?
WebStock is heavily short : 20% of float is short 80% Institutional investors. nice swing opportunity for a re-bounce to the upper "resistance" channel line. NASDAQ:CTIC Stock … WebMar 14, 2024 · Shares of CTIC stock opened at $4.47 on Tuesday. The stock has a market capitalization of $589.32 million, a price-to-earnings ratio of -5.26 and a beta of 0.91. CTI BioPharma has a twelve month ...
WebApr 12, 2024 · While ratings are subjective and will change, the latest CTI BioPharma ( CTIC) rating was a reiterated with a price target of $0.00 to $9.00. The current price CTI BioPharma ( CTIC) is trading at ... WebCTI BioPharma (CTIC) delivered earnings and revenue surprises of -55.56% and 15.24%, respectively, for the quarter ended December 2024. ... CTIC Stock Quotes API . CTIC …
Web2 days ago · Get the latest CTI BioPharma Corp CTIC detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. ... In fact, when combining a Zacks Rank #3 or … WebMar 29, 2024 · Buy CTI Biopharma Corp NASDAQ:CTIC stock? Extensive information, signals, indicators to help you decide if to buy or sell your stock. ... CTI BioPharma Corp. (NASDAQ:CTIC ) Q3 2024 Results Earnings Conference Call November 8, 2024 4:30 PM ET Company Participants Adam Craig - President, Chief Executive Officer and Interim …
WebCTI BioPharma Corp. analyst ratings, historical stock prices, earnings estimates & actuals. CTIC updated stock price target summary.
WebCti Biopharm (CTIC) reports earnings on 6/5/2024. Shares are down 15.5% since reporting last quarter. The Earnings Whisper Score gives the statistical odds for the stock ahead … open exe file downloadiowaska treatment centersWebLook out for CTIC's next earnings release on March 06, 2024. For the next earning release, we expect the company to report earnings of -$0.08 per share, reflecting a year-over … iowaska side effectsWeb1 day ago · CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies … open exchange rates londonWebCTIC Stock Summary. CTI BIOPHARMA CORP's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 3.63% of US listed stocks. ... CTI BioPharma Corp. (NASDAQ:CTIC) Q4 2024 Earnings Call Transcript March 6, 2024 Operator: Good morning, and welcome to the CTI BioPharma Fourth Quarter and Year … iowa skilled trades associationWeb2 days ago · SEATTLE, Wash., April 12, 2024 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today announced that the management team will participate in two upcoming investor … iowa skilled finish gradingWebApr 10, 2024 · Insiders have sold a total of 8,266,741 CTI BioPharma shares in the last 24 months for a total of $50,565,290.56 sold. This page (NASDAQ:CTIC) was last updated on 4/8/2024 by MarketBeat.com Staff. Get 30 Days of MarketBeat All Access Free. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: iowaska treatment for addiction